Propanc Biopharma Completes Reproduction run for its pancreatic drug

Australia |  News | 0 Comment | 15 Mar, 2018

Propanc Biopharma Inc., a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreat...Read more

Fresenius Medical Care gets recognition by ACHS

Australia |  News | 0 Comment | 15 Mar, 2018

The Australian Council on Healthcare Standards (ACHS), Australia's leading independent authority on healthcare, has recognised the high  standard of care that Fresenius Medical Care pr...Read more

Merck inks deal with Australian biotech firm Immutep

Australia |  News | 0 Comment | 13 Mar, 2018

Australia’s biotech giant Immutep has announced that it has entered into a clinical trial collaboration and supply agreement with Merck & Co to evaluate the combination of Immutep...Read more

Kerry Corning initiates phase 1 trial for narcoleptic drug

Australia |  News | 0 Comment | 13 Mar, 2018

Phase I clinical trials to assess its safety, human tolerance, and pharmacokinetic properties. XW10172 is the first compound that Kerry Corning has independently developed in innovative dru...Read more

Australian scientists to develop blood test for lung cancer

Australia |  News | 0 Comment | 11 Mar, 2018

A team of scientists from the Walter and Eliza Hall Institute of Medical Research in Australia have discovered a unique molecular signature of an aggressive lung cancer called adenocarcinom...Read more

'Cancer is an increasingly important health issue in the APAC region’

Australia |  Influencers | By Aishwarya venkatesh | 0 Comment | 09 Mar, 2018

Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new report by Grand View Research. The market is driven by increasing number ...Read more

Merck snaps up Australian firm Viralytics for $394M

Australia |  News | 0 Comment | 26 Feb, 2018

In  a bid to further broaden its immune-oncology portfolio, Merck has recently acquired Australian firm Viralytics for $394 million. The deal gives Merck access to Viralytics’s i...Read more

Atomo, RPS Diagnostics collaborate to address respiratory infections

Australia |  News | 0 Comment | 23 Feb, 2018

Australian firm Atomo Diagnostics has collaborated with US-based biotechnology company RPS Diagnostics for the development and commercialisation of next-generation FebriDx tests to diagnose...Read more

Zealand Pharma, Uniquest collaborate for gastrointestinal drugs

Australia |  News | 0 Comment | 21 Feb, 2018

The commercialisation company of The University of Queensland (UQ), Australia announced collaboration with Zealand Pharma to identify novel peptide therapeutics inspired by venoms as potent...Read more

Mundipharma acquires Australia's Tolmar; adds Eligard to its portfolio

Australia |  News | 0 Comment | 21 Feb, 2018

Mundipharma recently announced the acquisition of specialist pharmaceutical company, Tolmar Australia , including exclusive distribution rights for the oncology medication Eligard (leuprore...Read more

US's PCI Pharma services to acquire Australian packaging firm

Australia |  News | 0 Comment | 15 Feb, 2018

US firm PCI Pharma Services (PCI) has announced the acquisition of Australia-based Pharmaceutical Packaging Professionals (PPP). Located in Melbourne, Victoria, Australia, PPP is a recogniz...Read more

Proteomics International unites with CPR Pharma Services

Australia |  News | 0 Comment | 12 Feb, 2018

MedTech pioneer Proteomics International has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with a...Read more

Australian researchers identify drug to reverse alcohol effect

Australia |  News | 0 Comment | 10 Feb, 2018

A group of researchers from Queensland University of Technology, Australia has identified a drug that could potentially help our brains reboot and reverse the damage caused by heavy al...Read more

Allergan to acquire Australian biotech startup Elastagen

Australia |  News | 0 Comment | 09 Feb, 2018

Global pharma giant Allergen has struck a deal to acquire Australia's Elastagen , a clinical stage company developing medical device products based on recombinant tropoelastin, for an upfro...Read more

Japan, Australia researchers work on early Alzheimer’s detection

Australia |  News | 0 Comment | 06 Feb, 2018

Researchers at Florey Institute of Neuroscience and Mental Health, and University of Melbourne, Australia and Japanese National Center for Geriatrics and Gerontology Research Institute have...Read more

Starpharma to commence DEP cabazitaxel phase 1/2 trial

Australia |  News | 0 Comment | 31 Jan, 2018

Australia’s Starpharma today announced that it has received regulatory and ethics approvals to commence its phase 1/2 clinical trial for DEP cabazitaxel. The objectives of the trial a...Read more

Cynata signs MoU with US biotech company

Australia |  News | 0 Comment | 23 Jan, 2018

Cynata Therapeutics has signed a Memorandum of Understanding (MoU) with Celularity Inc., a US-based biotech company focusing on regenerative cells and tissues. According to the MoU, Celular...Read more

Patent is awarded to RNAi Technology of FuturaGene

Australia |  Regulatory | 0 Comment | 18 Jan, 2018

FuturaGene is a wholly owned subsidiary of Suzano Pulp and Paper, and Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO). The organization has announced...Read more